Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma

NCT00003502 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Contiguous Stage II Mantle Cell Lymphoma
Noncontiguous Stage II Mantle Cell Lymphoma
Stage III Mantle Cell Lymphoma
Stage IV Mantle Cell Lymphoma
Recurrent Mantle Cell Lymphoma

Interventions

DRUG: antineoplaston A10
DRUG: antineoplaston AS2-1
PROCEDURE: alternative product therapy
PROCEDURE: biological therapy
PROCEDURE: biologically based therapies
PROCEDURE: cancer prevention intervention
PROCEDURE: complementary and alternative therapy
PROCEDURE: differentiation therapy

Sponsor

Burzynski Research Institute